1670-0015 60 Day FRN

jstallworth on DSK7TPTVN1PROD with NOTICES

18466

Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices

Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W530, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W530, Bethesda, MD 20892–9750,
240–276–6442, [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Immunotherapy Trials Network.
Date: May 18, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W102,
Bethesda, MD 20892–9750, 240–276–6349,
[email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel; Technical
Evaluation Panel #1.
Date: May 23, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–7684, [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel; Technical
Evaluation Panel #2.
Date: May 24, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–7684, [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Drug Resistance 1.
Date: June 27–28, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

15:06 Apr 18, 2017

Jkt 241001

Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D.,
Chief, Program and Review Extramural Staff
Training Office, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Bethesda, MD 20892–9750, 240–276–6438,
[email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Drug Resistance 2.
Date: June 27–28, 2017.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Wlodek Lopaczynski, MD,
Ph.D., Assistant Director, Office of the
Director, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W514, Bethesda, MD
20892–9750, 240–276–6340, lopacw@
mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I—Transition to Independence.
Date: June 14–15, 2017.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crown Plaza National Airport, 1480
Crystal Drive, Arlington, VA 22202.
Contact Person: Delia Tang, MD, Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W602, Bethesda, MD 20892–9750,
240–276–6456, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 13, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07842 Filed 4–18–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2017–0015]

Notice of Request for Revision to and
Extension of a Currently Approved
Information Collection for ChemicalTerrorism Vulnerability Information
National Protection and
Programs Directorate, DHS.

AGENCY:

PO 00000

Frm 00051

Fmt 4703

Sfmt 4703

60-Day Notice and request for
comments; Revision of Information
Collection Request: 1670–0015.

ACTION:

The Department of Homeland
Security (DHS or the Department),
National Protection and Programs
Directorate (NPPD), Office of
Infrastructure Protection (IP),
Infrastructure Security Compliance
Division (ISCD), will submit the
following Information Collection
Request to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
Paperwork Reduction Act of 1995. DHS
proposes to remove five of the six
instruments previously approved to
support the Chemical-terrorism
Vulnerability Information (CVI) program
under the Chemical Facility Antiterrorism Standards (CFATS)
regulations, 6 CFR 27.400. DHS also
proposes to extend this collection with
revisions to reduce the estimated
burden for the remaining instrument in
this collection.
DATES: Comments are encouraged and
will be accepted until June 19, 2017.
This process is conducted in accordance
with 5 CFR 1320.8.
ADDRESSES: Interested persons are
invited to submit comments on the
proposed revision to, and extension of,
this approved information collection
through the Federal eRulemaking Portal
at http://www.regulations.gov. All
submissions received must include the
words ‘‘Department of Homeland
Security’’ and the docket number DHS–
2017–0015. Except as provided below,
comments received will be posted
without alteration at http://
www.regulations.gov, including any
personal information provided.
Comments that include trade secrets,
confidential commercial or financial
information, CVI,1 Sensitive Security
Information (SSI),2 or Protected Critical
Infrastructure Information (PCII) 3
should not be submitted to the public
regulatory docket. Please submit such
comments separately from other
comments in response to this notice.
Comments containing trade secrets,
confidential commercial or financial
information, CVI, SSI, or PCII should be
appropriately marked and packaged in
SUMMARY:

1 For more information about CVI see 6 CFR
27.400 and the CVI Procedural Manual at http://
www.dhs.gov/xlibrary/assets/chemsec_cvi_
proceduresmanual.pdf.
2 For more information about SSI see 49 CFR part
1520 and the SSI Program Web page at http://
www.tsa.gov.
3 For more information about PCII see 6 CFR part
29 and the PCII Program Web page at http://
www.dhs.gov/protected-critical-infrastructureinformation-pcii-program.

E:\FR\FM\19APN1.SGM

19APN1

Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices

jstallworth on DSK7TPTVN1PROD with NOTICES

accordance with applicable
requirements and submitted by mail to
the DHS/NPPD/IP/ISCD CFATS
Program Manager at the Department of
Homeland Security, 245 Murray Lane
SW., Mail Stop 0610, Arlington, VA
20528–0610.
FOR FURTHER INFORMATION CONTACT:
Questions and requests for additional
information may be directed to the
CFATS Program Manager via email at
[email protected] or telephone at (866)
323–2957.
SUPPLEMENTARY INFORMATION: Section
550 of the Homeland Security
Appropriations Act of 2007, Public Law
109–295 (2006), provided the
Department with the authority to
regulate the security of high-risk
chemical facilities. On April 9, 2007, the
Department issued an Interim Final
Rule (IFR), implementing this statutory
mandate at 72 FR 17688. In December
of 2014, the President signed into law
the Protecting and Securing Chemical
Facilities from Terrorist Attacks Act of
2014 (the CFATS Act of 2014), Public
Law 113–254, which authorized the
Chemical Facility Anti-Terrorism
Standards program in the Homeland
Security Act of 2002, as amended,
Public Law 107–296.4
The CFATS regulation (available at 6
CFR part 27) govern the security at
covered chemical facilities that have
been determined by the Department to
be at high risk for terrorist attack. See 6
CFR part 27. CFATS represents a
national-level effort to minimize
terrorism risk to such facilities. Its
design and implementation balance
maintaining economic vitality with
securing facilities and their surrounding
communities. The regulations were
designed, in collaboration with the
private sector and other stakeholders, to
take advantage of protective measures
already in place and to allow facilities
to employ a wide range of tailored
measures to satisfy the regulations’ RiskBased Performance Standards.
In 6 CFR 27.400, CFATS establishes
the requirements that covered persons
must follow to safeguard certain
documents and other information
developed under the regulations from
unauthorized disclosure. This
information is identified as ‘‘Chemicalterrorism Vulnerability Information’’
4 Section 2 of the CFATS Act of 2014 adds a new
Title XXI to the Homeland Security Act of 2002.
Title XXI contains new sections numbered 2101
through 2109. Citations to the Homeland Security
Act of 2002 throughout this document reference
those sections of Title XXI. In addition to being
found in amended versions of the Homeland
Security Act of 2002, those sections of Title XXI can
also be found in sec. 2 of the CFATS Act of 2014,
or in 6 U.S.C. 621–629.

VerDate Sep<11>2014

15:06 Apr 18, 2017

Jkt 241001

and, by law, receives protection from
public disclosure and misuse. The
instruments within this collection will
be used to manage the CVI program in
support of CFATS. The current
information collection for the CVI
program (IC 1670–0015) will expire on
September 30, 2017.5
The Department proposes the
following revisions from the previously
approved collection:
• Removal of the following
instruments: (1) ‘‘Determination of
CVI’’; (2) Determination of a ‘‘Need to
Know’’ by a Public Official’’; (3)
‘‘Disclosure of CVI Information; (4)
Notification of Emergency or Exigent
Circumstances’’; and (5) ‘‘Tracking Log
for CVI Received’’ from this collection.
As required by 5 CFR 1320.5, the
Department reevaluated the continued
need for each instrument in this
collection. This evaluation resulted in a
finding these instruments have
historically been used rarely.
The Department expects that in many
instances when the Department may
need or want to collect information
regarding emergency and/or
unauthorized disclosure of CVI, the
collection would not be covered by the
Paperwork Reduction Act because the
information would be collected during
the conduct of an investigation
involving specific individuals or
entities. See 44 U.S.C. 3518(c)(2) and 5
CFR 1320.4(a). The Department now
encourages State and local officials to
gain information regarding chemical
facilities in their jurisdictions from the
Department rather than from the
facilities. Accordingly, these officials
are now generally directed to IP
Gateway. The information that must be
collected routinely in order for such
officials to gain access to IP Gateway has
been authorized under OMB Control No.
1670–0009.
• A reduction of the number of
respondents for the CVI Authorization
instrument from 30,000 to 20,000. This
estimate is based on historical data and
the anticipated impact of the
Department’s revision of its Chemical
Security Assessment Tool (CSAT) and
enhancement of its risk tiering
methodology for the CFATS program.
See 81 FR 47001 (Jul. 20, 2016).

18467

The Department’s Methodology in
Estimating the Burden for the
Chemical-Terrorism Vulnerability
Information Authorization Number of
Respondents
The current information collection
estimated that 30,000 respondents
(rounded estimate) would submit a
request for a CVI Authorization
annually. Based on data collected
between CY 2014–2016, 13,115
respondents on average submitted
information to obtain CVI Authorization
on an annual basis. Historical data also
indicates that the peak number of
respondents for this instrument was
18,727 in 2008. However, the
Department expects that annual usage in
the next three years may increase from
the CY 2014–2016 average based on new
users who must become CVI authorized
to submit Top-Screens following the
Department’s revision of CSAT and
enhancement of its risk tiering
methodology. See 81 FR 47001 (Jul. 20,
2016). For these reasons, the
Department has revised the estimated
number of respondents to 20,000.
Estimated Time per Respondent
In the current information collection,
the estimated time per respondent to
prepare and submit a CVI Authorization
is one hour. Based on data collected
between Calendar Year (CY) 2014–2016
by the CSAT system measuring time
spent by users to complete this
instrument, the average response time is
0.50 hours (30 minutes). Based upon
this data, the Department proposes to
reduce the estimated time per
respondent to prepare and submit this
instrument to 0.50 hours (30 minutes).
Annual Burden Hours
The annual burden hours for the CVI
Authorization is [0.50 hours × 20,000
respondents × 1 response per
respondent], which equals 10,000 hours.
Total Capital/Startup Burden Cost
The Department provides access to
CSAT free of charge and assumes that
each respondent already has computer
hardware and access to the internet for
basic business needs. Therefore, there
are no annualized capital or start-up
costs incurred by chemical facilities of
interest or high-risk chemical facilities
for this information collection.
Total Recordkeeping Burden

5 The

current information collection for CVI may
be found at https://www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201303-1670-003.

PO 00000

Frm 00052

Fmt 4703

Sfmt 4703

There are no recordkeeping burden
costs incurred by chemical facilities of
interest or high-risk chemical facilities
for this information collection.

E:\FR\FM\19APN1.SGM

19APN1

18468

Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices

Total Annual Burden Cost
The Department assumes that the
majority of individuals who will
complete this instrument are Site
Security Officers (SSOs), although a
smaller number of other individuals
may also complete this instrument (e.g.,
Federal, State, and local government
employees and contractors). For the
purpose of this notice, the Department
maintains this assumption. Therefore, to
estimate the total annual burden, the
Department multiplied the annual
burden of 10,000 hours by the average
hourly wage rate of SSOs of $67.72 per
hour. Therefore, the total annual burden
cost for the CVI Authorization
instrument is $677,200 [10,000 total
annual burden hours × $67.72 per hour].
Analysis
Agency: Department of Homeland
Security, National Protection and
Programs Directorate, Office of
Infrastructure Protection, Infrastructure
Security Compliance Division.
Title: CFATS Chemical-terrorism
Vulnerability Information.
OMB Number: 1670–0015.
Instrument: Chemical-terrorism
Vulnerability Information
Authorization.
Frequency: ‘‘On occasion’’ and
‘‘Other’’.
Affected Public: Business or other forprofit.
Number of Respondents: 20,000
respondents (rounded estimate).
Estimated Time per Respondent: 0.50
hours.
Total Burden Hours: 10,000 annual
burden hours.
Total Burden Cost (capital/startup):
$0.
Total Recordkeeping Burden: $0.
Total Burden Cost: $677,200.
David Epperson,
Chief Information Officer, National Protection
and Programs Directorate, Department of
Homeland Security.
[FR Doc. 2017–07927 Filed 4–18–17; 8:45 am]
BILLING CODE 9110–9P–P

INTERNATIONAL TRADE
COMMISSION

jstallworth on DSK7TPTVN1PROD with NOTICES

[Investigation No. 337–TA–1002]

Certain Carbon and Alloy Steel
Products; Commission Determination
To Reset the Time for the Beginning of
the April 20, 2017, Oral Argument
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:

Notice is hereby given that
the U.S. International Trade

SUMMARY:

VerDate Sep<11>2014

15:06 Apr 18, 2017

Jkt 241001

Commission has determined to reset the
time for the beginning of the oral
argument, see 82 FR 16417–8 (Apr. 4,
2017), to 10 a.m. on April 20, 2017.
FOR FURTHER INFORMATION CONTACT:

Houda Morad, Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202)
708–4716. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
The
Commission instituted Investigation No.
337–TA–1002 on June 2, 2016, based on
a complaint filed by Complainant
United States Steel Corporation of
Pittsburgh, Pennsylvania (‘‘U.S. Steel’’),
alleging a violation of Section 337 of the
Tariff Act of 1930, as amended, 19
U.S.C. 1337. See 81 FR 35381–2 (June 2,
2016). The complaint alleges violations
of Section 337 based upon the
importation, the sale for importation, or
the sale after importation into the
United States of certain carbon and
alloy steel products by reason of: (1) A
conspiracy to fix prices and control
output and export volumes, the threat or
effect of which is to restrain or
monopolize trade and commerce in the
United States; (2) misappropriation and
use of trade secrets, the threat or effect
of which is to destroy or substantially
injure an industry in the United States;
and (3) false designation of origin or
manufacturer, the threat or effect of
which is to destroy or substantially
injure an industry in the United States.
Id. The notice of investigation identified
forty (40) respondents that are Chinese
steel manufacturers or distributors, as
well as some of their Hong Kong and
United States affiliates. Id. In addition
to the private parties, the Commission
assigned an Investigative Attorney from
the Commission’s Office of Unfair
Import Investigations (OUII), who
functions as an independent litigant or
party in the investigation. Id.

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

On August 26, 2016, Respondents
filed a motion to terminate U.S. Steel’s
antitrust claim under 19 CFR 210.21. On
November 14, 2016, the administrative
law judge (‘‘ALJ’’) issued an initial
determination (‘‘ID’’) (Order No. 38),
granting Respondents’ motion to
terminate Complainant’s antitrust claim
under 19 CFR 210.21 and, in the
alternative, under 19 CFR 210.18.
On December 19, 2016, the
Commission issued a Notice
determining to review the ID (Order No.
38). See 81 FR 94416–7 (Dec. 23, 2016).
In the December 19, 2016, Notice, the
Commission requested written
submissions from ‘‘[t]he parties to the
investigation, including the Office of
Unfair Import Investigations, and
interested government agencies,’’ and
set a date of March 14, 2017, for
possible oral argument. Id.
On March 3, 2017, the Commission
issued another notice seeking further
written submissions from the public and
rescheduling the date and time for the
oral argument to April 20, 2017 at 9:30
a.m. See 82 FR 13133–4 (Mar. 9, 2017).
On March 30, 2017, the Commission
issued another notice setting the
procedure for the oral argument. See 82
FR 16417–8 (Apr. 4, 2017).
The Commission has determined to
reset the time for the beginning of the
oral argument to 10 a.m. on April 20,
2017.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: April 12, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–07758 Filed 4–18–17; 8:45 am]
BILLING CODE 7020–02–P

DEPARTMENT OF JUSTICE
Antitrust Division
United States V. Danone S.A. and the
Whitewave Foods Company; Proposed
Final Judgment and Competitive
Impact Statement
Notice is hereby given pursuant to the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16(b)–(h), that a proposed
Final Judgment, Stipulation and
Competitive Impact Statement have
been filed with the United States
District Court for the District of
Columbia in United States of America v.

E:\FR\FM\19APN1.SGM

19APN1